Snap-8 vs Acetyl Tetrapeptide-5
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Acetyl Octapeptide-3, SNAP-8
SNAP-8 (Acetyl Octapeptide-3) is a synthetic eight-amino-acid topical cosmetic peptide, an extended cousin of Argireline that adds two residues to the same SNAP-25 mimic sequence. It is marketed as a needle-free way to soften expression lines, especially on the forehead and around the eyes. It is a cosmetic ingredient, not an approved drug, and the human evidence behind it is thin and mostly comes from the manufacturer.
Also: Eyeseryl, Ac-beta-Ala-His-Ser-His
Acetyl tetrapeptide-5 is a short synthetic peptide sold by Lipotec (now Lubrizol) as Eyeseryl, made for eye creams that target under-eye puffiness. The pitch is that it reduces fluid leaking into the tissue under the eyes. It is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Snap-8 | Acetyl Tetrapeptide-5 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The pitch is that SNAP-8 imitates the tip of SNAP-25, a protein nerves use to dock and release acetylcholine, the signal that tells facial muscles to contract. By competing for a spot in the SNARE complex that drives that release, the peptide is meant to dial down muscle firing and therefore the creasing those muscles cause, a gentler, reversible echo of how Botox works. The honest catch is that this is a proposed mechanism inferred from its sequence and from cell and test-tube work, not something confirmed to happen in living facial muscle after you rub on a cream. SNAP-8 is hydrophilic and fairly large, so getting enough of it down through the skin to reach muscle is the central unsolved problem. | The peptide is acetyl-beta-alanine-histidine-serine-histidine. The manufacturer's lab work claims three effects: it reduces vascular permeability (less fluid seeping out of small blood vessels, tested in an endothelial cell model), it inhibits glycation (sugar damage to proteins like collagen), and it has some ACE-inhibiting activity that is linked to fluid balance. All of that is in vitro and company-generated. An important reality check: under-eye bags have several causes, and a lot of them in older adults come from fat pads pushing forward and loose skin, not fluid. A peptide aimed at fluid cannot touch fat-pad bags, so even in the best case it fits morning puffiness better than structural eye bags. |
| Common Dosing | Limited community data available See research protocols | 1% of the Eyeseryl solution in an eye cream Twice daily |
| Administration | Topical (serums, creams) | Topical (eye creams, gels, serums) |
| Typical Duration | Ongoing use for maintained effects | 28-60 days in manufacturer studies; ongoing use to maintain any effect |
| Best Time to Take | Evening (topical) | Morning and evening, gently patted under the eyes |
Possible Side Effects May vary by individual |
|
|
| Research Summary | There is no robust independent clinical trial library for SNAP-8 specifically. Most of the impressive numbers you see, such as large percentage drops in wrinkle depth over four weeks, trace back to manufacturer literature rather than peer-reviewed, placebo-controlled studies. The science is best understood by looking at its parent peptide Argireline (acetyl hexapeptide-8), where the picture is genuinely mixed: the original 2002 Blanes-Mira study reported roughly 30 percent wrinkle-depth reduction with a 10 percent cream, but a later independent split-face human trial using VISIA imaging found no statistically significant difference between the peptide side and placebo. A 2025 review of acetyl hexapeptide-8 also flagged that skin-penetration data conflict sharply and that none of the in vivo studies actually confirmed muscle inhibition, the supposed mechanism. So for SNAP-8, treat the marketing claims with caution: plausible idea, real cosmetic-ingredient status, weak and largely company-sourced human proof. | We could not find an independent, peer-reviewed clinical trial of acetyl tetrapeptide-5. The evidence is manufacturer data reported in trade publications. Lipotec's best-known study used a 1% Eyeseryl cream on one eye and placebo on the other in male volunteers aged 30 to 65, twice daily for 28 days, and reported about a 30% reduction in under-eye puffiness volume, with most volunteers rating it positively. Another supplier document describes a 60-day study in 20 women using a cream with a very low peptide level, scored from photos by a dermatologist. Other summaries quote different numbers (17% to 21%) from studies we could not trace to an original paper. The studies differ in concentration, sex, length and how puffiness was measured, so they cannot be pooled. Independent ingredient databases rate the evidence as limited for exactly this reason. Bottom line: plausible for mild fluid puffiness, cheap to try in an eye cream, but not a fix for true eye bags and not backed by independent trials. |
Frequently Asked Questions: Snap-8 vs Acetyl Tetrapeptide-5
What is the difference between Snap-8 and Acetyl Tetrapeptide-5?
Snap-8 is a skin & hair peptide that snap-8 (acetyl octapeptide-3) is a synthetic eight-amino-acid topical cosmetic peptide, an extended cousin of argireline that adds two residues to the same snap-25 mimic sequence. it is marketed as a needle-free way to soften expression lines, especially on the forehead and around the eyes. it is a cosmetic ingredient, not an approved drug, and the human evidence behind it is thin and mostly comes from the manufacturer. Acetyl Tetrapeptide-5 is a skin & hair peptide that acetyl tetrapeptide-5 is a short synthetic peptide sold by lipotec (now lubrizol) as eyeseryl, made for eye creams that target under-eye puffiness. the pitch is that it reduces fluid leaking into the tissue under the eyes. it is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Snap-8 or Acetyl Tetrapeptide-5?
Neither is universally "better" - the choice depends on your specific goals. Snap-8 is typically used for skin & hair purposes, while Acetyl Tetrapeptide-5 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Snap-8 and Acetyl Tetrapeptide-5 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Snap-8 and Acetyl Tetrapeptide-5 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.